Log in to save to my catalogue

Status of Metabolomic Measurement for Insights in Alzheimer’s Disease Progression—What Is Missing?

Status of Metabolomic Measurement for Insights in Alzheimer’s Disease Progression—What Is Missing?

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10003384

Status of Metabolomic Measurement for Insights in Alzheimer’s Disease Progression—What Is Missing?

About this item

Full title

Status of Metabolomic Measurement for Insights in Alzheimer’s Disease Progression—What Is Missing?

Publisher

Switzerland: MDPI AG

Journal title

International journal of molecular sciences, 2023-03, Vol.24 (5), p.4960

Language

English

Formats

Publication information

Publisher

Switzerland: MDPI AG

More information

Scope and Contents

Contents

Alzheimer’s disease (AD) is an aging-related neurodegenerative disease, leading to the progressive loss of memory and other cognitive functions. As there is still no cure for AD, the growth in the number of susceptible individuals represents a major emerging threat to public health. Currently, the pathogenesis and etiology of AD remain poorly under...

Alternative Titles

Full title

Status of Metabolomic Measurement for Insights in Alzheimer’s Disease Progression—What Is Missing?

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10003384

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10003384

Other Identifiers

ISSN

1422-0067,1661-6596

E-ISSN

1422-0067

DOI

10.3390/ijms24054960

How to access this item